A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection

Adaptations of Avian Flu Virus Are a Cause for Concern

(2012) K. I. Berns et al.   SCIENCE

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance

(2010) R. B. Moss et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Poor Positive Accuracy of QuickVue Rapid Antigen Tests during the Influenza A (H1N1) 2009 Pandemic

(2010) H. L. Stevenson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Use of rapid influenza diagnostic tests under field conditions as a screening tool during an outbreak of the 2009 novel influenza virus: Practical considerations

(2010) Anthony R. Sambol et al.   JOURNAL OF CLINICAL VIROLOGY

Preparing for the Sickest Patients With 2009 Influenza A(H1N1)

(2009) Douglas B. White   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Historical Perspective — Emergence of Influenza A (H1N1) Viruses

(2009) Shanta M. Zimmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Persistent Legacy of the 1918 Influenza Virus

(2009) David M. Morens et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein

(2009) Gallen B. Triana-Baltzer et al.   PLoS One

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein

(2009) Gallen B. Triana-Baltzer et al.   PLoS One